Description
Industrial hemp production is not permitted in Israel; however, CBD is no longer considered a scheduled substance and will be allowed in foods and cosmetics once the Ministry of Health permits it. This report offers a comprehensive overview of the current framework in place for CBD, hemp and cannabis. It also discusses the possible future regulatory changes that may come into force in the coming years.
Reasons to buy
Israel’s government has been through a number of changes in recent times, and it is made up of different parties with differing ideologies and attitudes towards CBD and cannabis. This makes the future of CBD in Israel difficult to predict. However, changes are on the horizon, all of which can be found in our detailed regulatory report. It offers information on all policy areas, from cultivation and processing to finished products and the country’s recreational and medical cannabis regimes.
Table of contents
- Executive summary
- Outlook
- Hemp plant
- Extracts as finished product
- Finished products containing CBD and extracts
- Import/ export
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
Methodology
The research is completely original and conducted by CBD-Intel’s multilingual legal analysis team using several sources, including: online and offline resources and data, specialist legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground professionals.